Magdalena Alicja Zapała
Research Subjects
Magdalena Alicja Zapała has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Agnieszka Gawryś
Wojewódzki Szpital Specjalistyczny im. Stefana Kardynała Wyszyńskiego w Lublinie Al. Kraśnicka 100, 20-718 Lublin
7 shared publications - Agnieszka Środoń
Samodzielny Publiczny Zespół Opieki Zdrowotnej w Strzyżowie ul.700-lecia 1 38-100 Strzyżów
7 shared publications - Joanna Wilk
Wojewódzki Szpital Specjalistyczny im. Stefana Kardynała Wyszyńskiego w Lublinie Al. Kraśnicka 100, 20-718 Lublin
7 shared publications - Julia Czarnota
Franciszek Raszeja Memorial Municipal Hospital in Poznań Mickiewicza 2 street, 60-834 Poznań
7 shared publications - Katarzyna Cichoń
Independent Public Clinical Hospital No. 4 in Lublin. Jaczewskiego 8 street, 20-954 Lublin
7 shared publications - Małgorzata Chyćko
7th Navy Hospital in Gdańsk Polanki 117 street, 80-305 Gdańsk
7 shared publications
Latest Publications
- Open Access
- 25 August 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 46 (1) , 323-339
Supplementation with Omega-3 fatty acids in the supportive treatment of depression – systematic review
Omega-3 is a polyunsaturated fatty acid (PUFA) with a double bond present at the ω-3 carbon atom. Recently, many neurobiologists and psychiatrists have been studying the involvement of inflammatory factors and mechanisms in the pathogenesis of depression, including factors like an improper diet with an excess of omega-6, gut dysbiosis, obesity, and autoimmune diseases. The present study focuses on the impact of unsaturated fatty acids on mood improvement and cognitive processes in elderly patients with major depressive disorder (MDD) resistant to standard treatment. This form of depression is often associated with autoimmune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus, and inflammatory bowel diseases. The influence of omega-3 supplementation on depression prevention and its effects on childhood depression were also examined. It should be noted that some publications do not confirm the antidepressant effects of omega-3. However, this article provides evidence of the supportive role of omega-3 in depression treatment, based on neuroendocrine, metabolic, and immunological reactions. Objective: Literature review on the impact of omega-3 on depression treatment, considering its forms, inflammatory mechanisms, neuroendocrine factors, diet, lifestyle, and age. Materials and Methods: Literature review based on available sources from PubMed and Google Scholar. Conclusions: Omega-3 is a polyunsaturated fatty acid that positively affects the functioning of the body. Many research studies confirm its antidepressant and anti-inflammatory effects, making it a potential adjunctive treatment for depression, especially in elderly patients with major treatment-resistant depression (MDD) coexisting with other chronic diseases. The results of studies on the relationship between omega-3 and antidepressant action also depend on various environmental factors and lifestyle choices.
- 25 August 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 46 (1) , 323-339
Open AccessSupplementation with Omega-3 fatty acids in the supportive treatment of depression – systematic review
Omega-3 is a polyunsaturated fatty acid (PUFA) with a double bond present at the ω-3 carbon atom. Recently, many neurobiologists and psychiatrists have been studying the involvement of inflammatory factors and mechanisms in the pathogenesis of depression, including factors like an improper diet with an excess of omega-6, gut dysbiosis, obesity, and autoimmune diseases. The present study focuses on the impact of unsaturated fatty acids on mood improvement and cognitive processes in elderly patients with major depressive disorder (MDD) resistant to standard treatment. This form of depression is often associated with autoimmune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus, and inflammatory bowel diseases. The influence of omega-3 supplementation on depression prevention and its effects on childhood depression were also examined. It should be noted that some publications do not confirm the antidepressant effects of omega-3. However, this article provides evidence of the supportive role of omega-3 in depression treatment, based on neuroendocrine, metabolic, and immunological reactions. Objective: Literature review on the impact of omega-3 on depression treatment, considering its forms, inflammatory mechanisms, neuroendocrine factors, diet, lifestyle, and age. Materials and Methods: Literature review based on available sources from PubMed and Google Scholar. Conclusions: Omega-3 is a polyunsaturated fatty acid that positively affects the functioning of the body. Many research studies confirm its antidepressant and anti-inflammatory effects, making it a potential adjunctive treatment for depression, especially in elderly patients with major treatment-resistant depression (MDD) coexisting with other chronic diseases. The results of studies on the relationship between omega-3 and antidepressant action also depend on various environmental factors and lifestyle choices.
- Open Access
- 25 August 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 46 (1) , 283-296
Gastric lymphoma - epidemiology, clinical manifestations and current therapy management
Gastric lymphoma is a rare malignant disease, which in recent years has been showing an increasing incidence in the population. The development of MALT is most often the result of chronic Helicobacter pylori infection. Further chronic inflammation may result in malignant transformation of MALT to high-grade diffuse large B-cell lymphoma (DLBCL). However, DLBCL lymphomas most often arise de novo. The risk of primary gastric lymphoma increases with age. The symptoms of gastric lymphoma are very diverse and non-specific, which is why the knowledge about this disease and the differential diagnosis of diseases with similar symptoms play a very important role. The gold standard for diagnosing gastric lymphomas is upper GI endoscopy with biopsy, and sometimes additional imaging tests are necessary to make a proper diagnosis. It is very important to start treatment quickly - the first-line treatment is the eradication of Helicobacter pylori bacteria. Currently, we also have other therapeutic pathways that can change the course of the disease. The therapeutic plan should be individually selected for the needs of the individual patient. Changes detected in the early stages and treated quickly give patients a good chance of being cured. This publication is an attempt to summarize the current state of knowledge about the epidemiology, etiopathogenesis, clinical picture and therapeutic strategies in the case of gastric lymphoma.
- 25 August 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 46 (1) , 283-296
Open AccessGastric lymphoma - epidemiology, clinical manifestations and current therapy management
Gastric lymphoma is a rare malignant disease, which in recent years has been showing an increasing incidence in the population. The development of MALT is most often the result of chronic Helicobacter pylori infection. Further chronic inflammation may result in malignant transformation of MALT to high-grade diffuse large B-cell lymphoma (DLBCL). However, DLBCL lymphomas most often arise de novo. The risk of primary gastric lymphoma increases with age. The symptoms of gastric lymphoma are very diverse and non-specific, which is why the knowledge about this disease and the differential diagnosis of diseases with similar symptoms play a very important role. The gold standard for diagnosing gastric lymphomas is upper GI endoscopy with biopsy, and sometimes additional imaging tests are necessary to make a proper diagnosis. It is very important to start treatment quickly - the first-line treatment is the eradication of Helicobacter pylori bacteria. Currently, we also have other therapeutic pathways that can change the course of the disease. The therapeutic plan should be individually selected for the needs of the individual patient. Changes detected in the early stages and treated quickly give patients a good chance of being cured. This publication is an attempt to summarize the current state of knowledge about the epidemiology, etiopathogenesis, clinical picture and therapeutic strategies in the case of gastric lymphoma.
- Open Access
- 25 August 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 46 (1) , 216-232
The effect of antioxidants on the course and prevention of Alzheimer's disease on the example of vitamin E
Introduction and purpose of the work Alzheimer's disease is the most common cause of dementia. A small proportion of cases have a genetic etiology. Other factors that influence the development of Alzheimer's disease include old age, family history of the disease, head trauma, hypertension in middle age, excessive body weight, diabetes, as well as elevated plasma cholesterol levels. In the course of this disease, there is accumulation of β-amyloid and intracellular neurofibrillary tangles (NETs) phosphorylated tau. Oxidative stress is a significant factor influencing induction in the course of Alzheimer's disease. The aim of this study is to investigate the role of vitamin E on the course and prevention of Alzheimer's disease. State of the knowledge Currently, there is no known effective treatment or prevention of Alzheimer's disease. Given the properties of vitamin E, it seems reasonable to conduct research on its possible positive effects in the prevention and treatment of Alzheimer's disease. Numerous studies have been conducted to determine the role of vitamin E supplementation in the course of this disease. Many of them have shown a positive effect of eating a diet rich in vitamin E or taking this vitamin in the form of supplements on slowing the rate of progression of the disease and reducing the risk of its onset. However, there are also studies in which the role of vitamin E has not been confirmed. Summary Due to its properties, vitamin E can be considered as a means to reduce the risk of developing and progressing Alzheimer’s disease, but studies conducted so far are ambiguous on this issue. Further analysis should be carried out to confirm the efficacy of vitamin E in Alzheimer’s disease.
- 25 August 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 46 (1) , 216-232
Open AccessThe effect of antioxidants on the course and prevention of Alzheimer's disease on the example of vitamin E
Introduction and purpose of the work Alzheimer's disease is the most common cause of dementia. A small proportion of cases have a genetic etiology. Other factors that influence the development of Alzheimer's disease include old age, family history of the disease, head trauma, hypertension in middle age, excessive body weight, diabetes, as well as elevated plasma cholesterol levels. In the course of this disease, there is accumulation of β-amyloid and intracellular neurofibrillary tangles (NETs) phosphorylated tau. Oxidative stress is a significant factor influencing induction in the course of Alzheimer's disease. The aim of this study is to investigate the role of vitamin E on the course and prevention of Alzheimer's disease. State of the knowledge Currently, there is no known effective treatment or prevention of Alzheimer's disease. Given the properties of vitamin E, it seems reasonable to conduct research on its possible positive effects in the prevention and treatment of Alzheimer's disease. Numerous studies have been conducted to determine the role of vitamin E supplementation in the course of this disease. Many of them have shown a positive effect of eating a diet rich in vitamin E or taking this vitamin in the form of supplements on slowing the rate of progression of the disease and reducing the risk of its onset. However, there are also studies in which the role of vitamin E has not been confirmed. Summary Due to its properties, vitamin E can be considered as a means to reduce the risk of developing and progressing Alzheimer’s disease, but studies conducted so far are ambiguous on this issue. Further analysis should be carried out to confirm the efficacy of vitamin E in Alzheimer’s disease.
- Open Access
- 25 August 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 46 (1) , 156-175
The analysis of the role of probiotics in preventing and reducing the risk of atherosclerosis - literature review
Atherosclerosis is a chronic inflammatory disease of large and medium-sized arteries underlying cardiovascular disease (CVD), such as myocardial infarction, cerebrovascular stroke and peripheral vascular disease, which is the leading cause of mortality worldwide. It is characterized by deposition of modified lipoproteins, accumulation of immune cells and formation of fibrous tissue in the vessel wall. The disease occurs in vessels throughout the body and affects the function of almost all organs, including the lymphatic system, bone marrow, heart, brain, pancreas, adipose tissue, liver, kidneys and gastrointestinal tract. Many clinical trials of anti-atherosclerotic drugs have not provided satisfactory results, and their use is associated with a significant residual risk of cardiovascular disease and various side effects.Probiotics have recently attracted considerable interest for their potential use to prevent atherosclerosis. This review will discuss the mechanisms of effect and impact of probiotics on atherosclerosis risk factors, as well as the potential use of probiotics in the prevention of atherosclerosis, based on a review of the available literature in the PubMed database from 2019 to 2023 using key words on studies related to this topic.
- 25 August 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 46 (1) , 156-175
Open AccessThe analysis of the role of probiotics in preventing and reducing the risk of atherosclerosis - literature review
Atherosclerosis is a chronic inflammatory disease of large and medium-sized arteries underlying cardiovascular disease (CVD), such as myocardial infarction, cerebrovascular stroke and peripheral vascular disease, which is the leading cause of mortality worldwide. It is characterized by deposition of modified lipoproteins, accumulation of immune cells and formation of fibrous tissue in the vessel wall. The disease occurs in vessels throughout the body and affects the function of almost all organs, including the lymphatic system, bone marrow, heart, brain, pancreas, adipose tissue, liver, kidneys and gastrointestinal tract. Many clinical trials of anti-atherosclerotic drugs have not provided satisfactory results, and their use is associated with a significant residual risk of cardiovascular disease and various side effects.Probiotics have recently attracted considerable interest for their potential use to prevent atherosclerosis. This review will discuss the mechanisms of effect and impact of probiotics on atherosclerosis risk factors, as well as the potential use of probiotics in the prevention of atherosclerosis, based on a review of the available literature in the PubMed database from 2019 to 2023 using key words on studies related to this topic.
- Open Access
- 19 August 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 45 (1) , 247-256
When a close person suddenly changes their behavior – dementia in young people. A case report
The aim of our study is to present a case report of a young patient with rapidly progressive behavioral changes. A 39-year-old well functioning man in a short period of time began to show symptoms like agressive towards his family members, binge eating, apathy, difficulties with social interactions, reduced verbal fluency and poverty of speech, disorders in executive functions and restlessness and anxiety. This behavioral changes appeared in a short period of time (6 months). The concerned family, alarmed by this unusual behavior not previously observed, sought medical help. The patient was disoriented, not receptive to arguments about his atypical behavior, and unaware of the existing problem. A comprehensive diagnostic evaluation (including laboratory, imaging, and neuropsychological assessments) was conducted during the hospital stay. MRI scan showed substantial cortical atrophy in frontal and temporal lobes. Based on the clinical status, typical MRI and neuropsychological examination, the patient was diagnosed with frontotemporal dementia (FTD). The patient received a diagnosis in a very short period of time, which is not typical in establishing a diagnosis for this particular medical condition. The symptoms are often nonspecific, which delays the diagnosis or leads to an incorrect preliminary diagnosis of another medical condition. Difficulties in diagnosing also arise from the non-specific symptoms, which are often overlooked by the patient themselves. It is important to emphasize the crucial role of family members and close associates in recognizing the initial symptoms and making attempts to diagnose the disease. It is also important to provide support and care for the patient's family, for whom the diagnosis of FTD becomes challenging and burdening.
- 19 August 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 45 (1) , 247-256
Open AccessWhen a close person suddenly changes their behavior – dementia in young people. A case report
The aim of our study is to present a case report of a young patient with rapidly progressive behavioral changes. A 39-year-old well functioning man in a short period of time began to show symptoms like agressive towards his family members, binge eating, apathy, difficulties with social interactions, reduced verbal fluency and poverty of speech, disorders in executive functions and restlessness and anxiety. This behavioral changes appeared in a short period of time (6 months). The concerned family, alarmed by this unusual behavior not previously observed, sought medical help. The patient was disoriented, not receptive to arguments about his atypical behavior, and unaware of the existing problem. A comprehensive diagnostic evaluation (including laboratory, imaging, and neuropsychological assessments) was conducted during the hospital stay. MRI scan showed substantial cortical atrophy in frontal and temporal lobes. Based on the clinical status, typical MRI and neuropsychological examination, the patient was diagnosed with frontotemporal dementia (FTD). The patient received a diagnosis in a very short period of time, which is not typical in establishing a diagnosis for this particular medical condition. The symptoms are often nonspecific, which delays the diagnosis or leads to an incorrect preliminary diagnosis of another medical condition. Difficulties in diagnosing also arise from the non-specific symptoms, which are often overlooked by the patient themselves. It is important to emphasize the crucial role of family members and close associates in recognizing the initial symptoms and making attempts to diagnose the disease. It is also important to provide support and care for the patient's family, for whom the diagnosis of FTD becomes challenging and burdening.
- Open Access
- 27 June 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 42 (1) , 46-50
The influence of bipolar disorder medication on sexual performance
Sexual performance is one of the key aspects of good quality of life, both in healthy people and patients suffering from various mental disorders. Besides many reasons causing poor sexual performance, like mental condition itself, medication can alter one's ability to achieve satisfaction in sex. Sexual dysfunction is listed among one of side effects of psychotropic medications. Aim of this work is to determine an influence of pharmacotherapy on sexual function in patients with bipolar disorder. Results: Pharmacotherapy in patients suffering from bipolar disorder can cause a multitude of side effects, including malfunction in sexual performance. Extent of severity in poor sexual life depends on many factors among which are: type of drug taken, whether there are one or more drugs taken at the same time. Seems to be observed that quetiapine shows the least negative effect on sexual performance. Additionally, highest risk of sexual malfunction is observed in patients with polytherapy. Conclusion: Besides topics investigated in the following research, there are additional factors like duration and severity of the disease, gender and age. There are many variables needed to be taken into consideration, but there is potential of choosing proper medication for a patient with least possible side effects and to allow them to perform more successful sex life, which directly corresponds with better quality of life.
- 27 June 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 42 (1) , 46-50
Open AccessThe influence of bipolar disorder medication on sexual performance
Sexual performance is one of the key aspects of good quality of life, both in healthy people and patients suffering from various mental disorders. Besides many reasons causing poor sexual performance, like mental condition itself, medication can alter one's ability to achieve satisfaction in sex. Sexual dysfunction is listed among one of side effects of psychotropic medications. Aim of this work is to determine an influence of pharmacotherapy on sexual function in patients with bipolar disorder. Results: Pharmacotherapy in patients suffering from bipolar disorder can cause a multitude of side effects, including malfunction in sexual performance. Extent of severity in poor sexual life depends on many factors among which are: type of drug taken, whether there are one or more drugs taken at the same time. Seems to be observed that quetiapine shows the least negative effect on sexual performance. Additionally, highest risk of sexual malfunction is observed in patients with polytherapy. Conclusion: Besides topics investigated in the following research, there are additional factors like duration and severity of the disease, gender and age. There are many variables needed to be taken into consideration, but there is potential of choosing proper medication for a patient with least possible side effects and to allow them to perform more successful sex life, which directly corresponds with better quality of life.
- Open Access
- 29 May 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 35 (1) , 94-112
Evaluation of the effectiveness and safety of anti-obesity drugs - an update on the current state of knowledge on available and investigational drugs
Introduction and purpose of the work: Disturbing epidemiological data indicate that obesity has become a global problem and has reached the size of a worldwide epidemic. The search for effective methods of combating obesity seems to be an important step in preventing cardiovascular diseases and numerous metabolic complications. The aim of the study is to assess the effectiveness and safety of available drugs used in the treatment of obesity in accordance with the current state of knowledge and to present new pharmacological options. State of knowledge: Pharmacotherapy provides overweight and obese adults with the opportunity to support weight reduction in the event of failure of lifestyle modifications. Currently registered drugs for the treatment of obesity are orlistat, lorcaserin, liraglutide and combination preparations: phentermine/topiramate and naltrexone SR/bupropion SR. Summary: Among the currently available drugs for obesity, the most effective are phentermine/topiramate and liraglutide. Research is also underway on the use of new substances that promote weight loss. The latest data on semaglutide and tirzepatide have better efficacy results compared to currently available drugs with a similar safety profile. The latest data on semaglutide and tirzepatide improve the efficacy results of current drugs while maintaining a similar safety profile. It seems that the best way to lose excessive body weight should be an individualized approach to the treatment of obesity among patients, taking into account i.a. degree of obesity, comorbidities, contraindications, patient preferences, cost and availability of treatment. In clinical practice, when choosing a drug, we should pay attention to side effects and find a balance between effectiveness and safety. In addition to weight loss, the use of anti-obesity drugs has many additional benefits, including improvement of the cardiometabolic profile, reduction of glucose, insulin and lipids in the blood.
- 29 May 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 35 (1) , 94-112
Open AccessEvaluation of the effectiveness and safety of anti-obesity drugs - an update on the current state of knowledge on available and investigational drugs
Introduction and purpose of the work: Disturbing epidemiological data indicate that obesity has become a global problem and has reached the size of a worldwide epidemic. The search for effective methods of combating obesity seems to be an important step in preventing cardiovascular diseases and numerous metabolic complications. The aim of the study is to assess the effectiveness and safety of available drugs used in the treatment of obesity in accordance with the current state of knowledge and to present new pharmacological options. State of knowledge: Pharmacotherapy provides overweight and obese adults with the opportunity to support weight reduction in the event of failure of lifestyle modifications. Currently registered drugs for the treatment of obesity are orlistat, lorcaserin, liraglutide and combination preparations: phentermine/topiramate and naltrexone SR/bupropion SR. Summary: Among the currently available drugs for obesity, the most effective are phentermine/topiramate and liraglutide. Research is also underway on the use of new substances that promote weight loss. The latest data on semaglutide and tirzepatide have better efficacy results compared to currently available drugs with a similar safety profile. The latest data on semaglutide and tirzepatide improve the efficacy results of current drugs while maintaining a similar safety profile. It seems that the best way to lose excessive body weight should be an individualized approach to the treatment of obesity among patients, taking into account i.a. degree of obesity, comorbidities, contraindications, patient preferences, cost and availability of treatment. In clinical practice, when choosing a drug, we should pay attention to side effects and find a balance between effectiveness and safety. In addition to weight loss, the use of anti-obesity drugs has many additional benefits, including improvement of the cardiometabolic profile, reduction of glucose, insulin and lipids in the blood.
- Open Access
- 29 May 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 35 (1) , 51-61
The influence of the gut microbiome on polycystic ovary syndrome - literature review
The intestinal microbiome is an integral part of our body, and a normal intestinal microflora allows the body to maintain homeostasis. Dysbiosis can contribute to the development of many cardiovascular diseases, can affect the development of cancer, gynecological diseases. Polycystic ovary syndrome affects many women of reproductive age and leads to a decrease in the quality of life of patients facing this problem. The main symptoms of PCOS are: menstrual disorders, problems with getting pregnant, skin problems (acne, hirsutism), obesity. The mainstay of treatment is hormonal medication, metformin. There are reports of supplementing drug therapy with diet, a healthy lifestyle. In recent years, there have been a number of studies looking for a relationship between the state of the intestinal microflora and polycystic ovary syndrome. In our work, we reviewed the available literature in the PuBMed database from 2019 to 2023 with key words on the studies related to our topic.
- 29 May 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 35 (1) , 51-61
Open AccessThe influence of the gut microbiome on polycystic ovary syndrome - literature review
The intestinal microbiome is an integral part of our body, and a normal intestinal microflora allows the body to maintain homeostasis. Dysbiosis can contribute to the development of many cardiovascular diseases, can affect the development of cancer, gynecological diseases. Polycystic ovary syndrome affects many women of reproductive age and leads to a decrease in the quality of life of patients facing this problem. The main symptoms of PCOS are: menstrual disorders, problems with getting pregnant, skin problems (acne, hirsutism), obesity. The mainstay of treatment is hormonal medication, metformin. There are reports of supplementing drug therapy with diet, a healthy lifestyle. In recent years, there have been a number of studies looking for a relationship between the state of the intestinal microflora and polycystic ovary syndrome. In our work, we reviewed the available literature in the PuBMed database from 2019 to 2023 with key words on the studies related to our topic.
- Open Access
- 20 May 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 32 (1) , 22-30
Obsessive - compulsive disorder - course during pregnancy, exacerbation factors - literature review
Introduction and purpose of the work: The period of pregnancy and puerperium is the time of increased vulnerability for mother’s mental deterioration. While disorders such as perinatal depression have been detailed, an impact of pregnancy on the course of other mental disorders such as OCD is less investigated. The purpose of this work was to draw attention to the factors that may influence exacerbation of obsessions and compulsions in pregnancy and during the postpartum period. The most common obsessions and compulsions of pregnant women and the influence of mother’s OCD on the newborn have also been described in this research. State of knowledge: Factors such as mother’s age, duration of pregnancy, method of delivery may be predictors of aggravation of obsessions and compulsions. Gestational diabetes, thyroid hormones levels, personality disorders of the mother, stress, cultural beliefs also have an impact on mother’s OCD. Infant being infected or hurt are the most common obsession subjects while cleaning and checking the baby happen to be the most frequent compulsions. Summary: It is important to disseminate knowledge about the course of OCD during pregnancy and postpartum period and pay attention to the inflammatory factors for earlier diagnosis and treatment. More research about factors worsening OCD through pregnancy are needed to be conducted.
- 20 May 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 32 (1) , 22-30
Open AccessObsessive - compulsive disorder - course during pregnancy, exacerbation factors - literature review
Introduction and purpose of the work: The period of pregnancy and puerperium is the time of increased vulnerability for mother’s mental deterioration. While disorders such as perinatal depression have been detailed, an impact of pregnancy on the course of other mental disorders such as OCD is less investigated. The purpose of this work was to draw attention to the factors that may influence exacerbation of obsessions and compulsions in pregnancy and during the postpartum period. The most common obsessions and compulsions of pregnant women and the influence of mother’s OCD on the newborn have also been described in this research. State of knowledge: Factors such as mother’s age, duration of pregnancy, method of delivery may be predictors of aggravation of obsessions and compulsions. Gestational diabetes, thyroid hormones levels, personality disorders of the mother, stress, cultural beliefs also have an impact on mother’s OCD. Infant being infected or hurt are the most common obsession subjects while cleaning and checking the baby happen to be the most frequent compulsions. Summary: It is important to disseminate knowledge about the course of OCD during pregnancy and postpartum period and pay attention to the inflammatory factors for earlier diagnosis and treatment. More research about factors worsening OCD through pregnancy are needed to be conducted.
- Open Access
- 9 May 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 13 (1) , 88-107
Collagen supplementation - does it bring real benefits?
Collagen is a protein and one of the main building blocks of our skin. It is found in bones, tendons, ligaments, internal organs, blood vessels, and the lining of the intestines. In our body, collagen enables the cohesion of tissues and organs, affects hydration, resistance and elasticity of the skin, reduces the risk of developing degenerative joint diseases. Its production decreases with age. As a result, more and more people are taking collagen supplements. It has been proven that doing so can bring many benefits to the body. Taking collagen orally can be an effective way to improve the quality of the skin, increase hydration and delay the aging process. Collagen peptides are potential therapeutic agents for treating osteoarthritis and maintaining joint health. Collagen supplementation may be an element of preventive medicine in the field of cardiovascular diseases. as it significantly reduces fat mass and increases lean mass, it also leads to lower LDL concentrations. A beneficial effect was also noted on hair and nails, as well as on brain function.
- 9 May 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 13 (1) , 88-107
Open AccessCollagen supplementation - does it bring real benefits?
Collagen is a protein and one of the main building blocks of our skin. It is found in bones, tendons, ligaments, internal organs, blood vessels, and the lining of the intestines. In our body, collagen enables the cohesion of tissues and organs, affects hydration, resistance and elasticity of the skin, reduces the risk of developing degenerative joint diseases. Its production decreases with age. As a result, more and more people are taking collagen supplements. It has been proven that doing so can bring many benefits to the body. Taking collagen orally can be an effective way to improve the quality of the skin, increase hydration and delay the aging process. Collagen peptides are potential therapeutic agents for treating osteoarthritis and maintaining joint health. Collagen supplementation may be an element of preventive medicine in the field of cardiovascular diseases. as it significantly reduces fat mass and increases lean mass, it also leads to lower LDL concentrations. A beneficial effect was also noted on hair and nails, as well as on brain function.